FDA clears Sail Fusion’s BowTie Sacroiliac Fusion System
April 23, 2024
Sail Fusion today announced it received FDA 510(k) clearance for its BowTie Sacroiliac Fusion System.
Sail Fusion today announced it received FDA 510(k) clearance for its BowTie Sacroiliac Fusion System.
Front Line Medical Technologies today announced it received CE mark approval for its COBRA-OS device.
Penumbra (NYSE:PEN) announced today that it received FDA clearance for and began the launch of its Lightning Flash 2.0 CAVT system.
PLEASANTON, Calif., April 22, 2024 /PRNewswire/ — Expanse ICE announced today the ICE Aspiration System has received 510(k) clearance from the U.S. Food and Drug Administration. This announcement introduces a new and exciting player in the peripheral thrombectomy market.
Philips (NYSE: PHG)+
announced today that the FDA granted 510(k) clearance for its Zenition 30 mobile C-arm.
Lumicell developed the technology to help physicians detect residual cancer in the breast cavity after surgery.
The Osia System, which launched commercially in 2020, is indicated for people with conductive hearing loss, mixed hearing loss and single-sided sensorineural deafness (SSD)
Scopio can now add the application to its imaging platforms that allow users to view blood samples digitally rather than under a microscope.
Lumicell today announced it received FDA approval for its LumiSystem direct visualization system for breast cancer removal.
The company’s 3rd FDA clearance accelerates the shift to AI-powered digital hematopathology, enhancing diagnostic speed and patient care